Background and Purpose-Light-to-moderate alcohol consumption is associated with reduced risk for cardiovascular disease, whereas high serum ␥-glutamyltransferase (GGT) level is associated with cardiovascular disease. However, whether light-to-moderate alcohol drinking is still related to reduced risk of cardiovascular disease irrespective of GGT level is uncertain. Methods-We performed a 12.5-year cohort study of 2336 men (excluding exdrinkers) who were free from cardiovascular disease. They were classified into 4 groups according to alcohol consumption: never, and current light, moderate, or heavy drinker. The multivariate-adjusted hazard ratios of alcohol consumption for incidence of coronary artery disease, total stroke, and ischemic stroke compared with those of never drinkers were assessed with stratification by GGT median (32 IU/L). Results-In participants with GGT Ͼ32 IU/L, the hazard ratios of all current drinkers for total and ischemic stroke were higher than those of never drinkers. However, in all current drinkers with GGT Յ32 IU/L, the multivariate-adjusted hazard ratios for total and ischemic stroke were lower than in never drinkers. Conclusions-In men with above GGT median, alcohol drinking even with light-to-moderate consumption could be a risk factor for ischemic stroke. (Stroke. 2011;42:00-00.)
L ight-to-moderate alcohol drinking is associated with reduced risk of cardiovascular disease (CVD). 1, 2 On the other hand, high serum ␥-glutamyltransferase (GGT) level is associated with increased risk of CVD. 3, 4 However, it is unclear whether light-to-moderate alcohol drinking is still associated with lower risk of CVD irrespective of GGT level. We performed a cohort study in Japanese men to examine the relationships of alcohol drinking with stroke and coronary artery disease (CAD) events after stratification by GGT level.
Methods
The Suita Study, a cohort study of CVD, was established in 1989. The details of the methods have been described elsewhere. 5 In the present study, 2336 men aged 30 to 79 years who were free from CVD and did not include exdrinkers were followed for 12.5Ϯ5.3 years. Disease event included the first stroke or CAD incidence or mortality from stroke or CAD. This study was approved by the Institutional Review Board of the National Cerebral and Cardiovascular Center.
In the baseline survey, alcohol consumption was determined by alcohol intake per typical week and calculated as ethanol intake per day. We defined 11.5 g of ethanol (half a gou, a traditional Japanese unit) as 1 drink; this is nearly equal to 1 "standard" drink in most countries. 6 Participants were classified into 4 groups according to alcohol consumption.
We calculated the multivariate-adjusted hazard ratios (HRs) and 95% CIs for CAD, total stroke and ischemic stroke in each drinking group compared with never drinkers by Cox proportional hazards model after adjusting for possible confounders. The same statistical models were used after the participants were classified according to GGT median (32 IU/L) at the baseline survey and when never drinkers with GGT Յ32 IU/L were used as a reference in all participants. All statistical analyses were performed by using SPSS statistical software, Version 15.0 J (SPSS, Tokyo, Japan).
Results
The baseline characteristics of the participants are shown in Table 1 .
During the follow-up period, 109 CAD and 113 total stroke cases occurred. The multivariate-adjusted HRs for CAD were -transformed) , presence of hypertension, diabetes and hypercholesterolemia, and smoking status (current or noncurrent).
GGT indicates ␥-glutamyltransferase; HR, hazard ratio.
lower in drinkers than in never drinkers with statistical significance in moderate and heavy drinkers. The HRs for total and ischemic stroke were similar among all groups (data not shown).
In participants with GGT Յ32 IU/L, the HRs for CAD, total stroke, and ischemic stroke were lower among all current-drinker groups than in never drinkers (Table 2 ). In participants with GGT Ͼ32 IU/L, HRs for CAD were still lower in moderate and heavy drinkers than in never drinkers. However, for total and ischemic stroke, HRs were higher among current drinkers than in never drinkers. These tendencies did not change when never drinkers with GGT Յ32 IU/L were used as a reference in all participants (Figure) , although the HRs were different from those presented in Table 2 .
Discussion
To our knowledge, this is the first cohort study to show the consumption-specific risks of alcohol drinking for CVD stratified by GGT levels. Generally, habitual drinkers are interested to know, "What is the upper limit of alcohol intake?" and "Who should not drink?" The answer from our study is "Especially from the viewpoint of stroke prevention, serum GGT levels should be examined; people with high GGT levels should not drink alcohol," although we need to accumulate more evidence concerning this question in future studies.
Increased GGT levels are associated with CVD risk factors such as high blood pressure, high cholesterol, and high blood glucose levels 7 and with high levels of oxidative stress markers. 8 These risk factors might be associated with our current results, although we adjusted for the presence of hypertension, hypercholesterolemia, and diabetes mellitus in the baseline survey.
This study had several limitations. First, because of the small number of cases, we could not assess the risk of hemorrhagic stroke. Second, use of a single GGT measurement and a single assessment of alcohol consumption at the baseline survey might have caused misclassification or underestimation of the relationships among alcohol drinking, GGT, and events because of regression dilution bias. 9 Third, we could not accurately validate our questionnaire for alcohol consumption and investigate the effects of binge drinking, type of alcoholic beverage consumed, 6 and genetic differences. 10 Fourth, the small event number of never drinkers with GGT Ͼ32 IU/L was vulnerable to fluctuation and could affect the results.
In conclusion, for individuals with relatively high GGT levels, alcohol drinking could be a risk factor for ischemic stroke. Examination of serum GGT levels might be important for the evaluation of ischemic stroke risk in consumers of alcohol.
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Figure.
Risk of alcohol consumption for CVD according to GGT level. *PϽ0.05 compared to never-drinkers with GGT median and below. HR indicates multivariate-adjusted hazard ratio adjusted for the same confounders presented in Table 2 ; CVD, cardiovascular disease; GGT, ␥-glutamyltransferase.
